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Abstract
Introduction and background Autoimmune pancreatitis (AIP) is a rare disease that closely mimics pancreatic cancer (PC) in
its presentation. It is very important for clinicians to distinguish one from the other because their treatment and prognosis are
vastly different. Typical radiological imaging findings, in particular observation of diffusely or segmentally narrowed main
pancreatic duct (MPD) with an irregular wall by endoscopic retrograde cholangiopancreatography (ERCP), are essential for
making the diagnosis of AIP. On the other hand, MPD obstruction is one of the most frequent features on ERCP.
Case report We report a rare case of a patient with focal mass-forming AIP strongly suspected of being PC because of MPD
obstruction on ERCP.
Conclusion It was difficult to distinguish PC from AIP with current diagnostic modalities. We will continue to make an
effort to distinguish between the two disorders to prevent unnecessary surgery.
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Autoimmune pancreatitis (AIP) is a rare disease that closely
mimics pancreatic cancer (PC) in its presentation. It is very
important for clinicians to distinguish one from the other
because their treatment and prognosis are vastly different.
In 2006, the Japanese Pancreas Society proposed clinical
diagnostic criteria for AIP based on a combination of
clinical, laboratory, imaging, and histological findings.
1
According to these criteria, typical radiological imaging
findings, in particular observation of diffusely or segmen-
tally narrowed main pancreatic duct (MPD) with an
irregular wall by endoscopic retrograde cholangiopancrea-
tography (ERCP), are essential for making the diagnosis of
AIP. On the other hand, MPD obstruction is one of the most
frequent features on ERCP.
Here, we report a rare case of a patient with focal mass-
forming (FMF) AIP strongly suspected of being PC
because of MPD obstruction on ERCP.
Case Report
A previously healthy 79-year-old man with epigastric pain
was admitted to another hospital. After examination, he was
diagnosed as having acute pancreatitis due to a tumor of the
pancreatic tail. After treatment for pancreatitis, he was
referred to our hospital for further examination and
treatment of the tumor. The patient's blood chemistry data
were within normal limits except for slightly elevated
serum pancreatic amylase (264 IU/l) and lipase levels
(430 IU/l). Serum levels of CA19-9 and CEA were both
normal. Serum gamma globulin and total IgG were normal,
but IgG4 was elevated (256 mg/dl). Serum autoantibodies
and rheumatoid factor were negative. Dynamic CT imaging
revealed an irregular mass measuring 40×23 mm in the tail
of the pancreas. The tumor was not enhanced on the arterial
phase and slightly enhanced on the portal phase (Fig. 1a).
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DOI 10.1007/s11605-011-1543-5The splenic vein was obstructed by the tumor. MRI imaging
showed that the intensity decreased in the T1-weighted
images of the pancreas and increased in the T2-weighted
images. Endoscopic ultrasonography (EUS) revealed a
hypoechoic lesion detected in the tail of the pancreas. EUS-
guided fine needle aspiration (EUS-FNA), however, did not
reveal any cancer cells. 18-Fluorodeoxyglucose positron
emission tomography (FDG-PET) showed hot spots of FDG
uptake at the site of the pancreatic mass. No extrapancreatic
lesions were detected. ERCP revealed an obstruction of the
MPD at the site of the tumor (Fig. 1b). Insertion of a
guidewire to the distal MPD was impossible. Brush cytology
was negative for cancer cells. We suspected PC concomitant
with AIP or rather than AIP. The patient underwent a distal
pancreatectomy with an uneventful postoperative course.
Gross inspection of the resected specimen revealed a
diffusely enlarged and firm pancreas. Histologically, it was
remarkable for an intense mixed inflammatory cell infiltrate
predominantly composed of lymphocytes and plasma
cells, and centered on the pancreatic ducts. The inflam-
mation was associated with significant acinar dropout
and parenchymal fibrosis. An obliterative venulitis was
noted at the leading edges of the inflammatory cell infiltrate.
Immunohistochemical labeling with an antibody to IgG4
revealed large numbers of IgG4-expressing plasma cells.
Discussion
Although diagnosis of AIP has improved thanks to a
growing awareness of the condition and proposed diagnostic
criteria,
1 there remains no practical strategy to differentiate
PC from AIP. One must distinguish between the two
disorders to prevent unnecessary surgery or delayed initia-
tion of corticosteroid therapy. However, about 3–5% of
patients undergoing pancreatic resection for presumed PC
in fact has AIP.
2 Kamisawa et al.
3 reported that 7 of 37
(18.9%) AIP patients had surgery because they were
misdiagnosed as having PC or bile duct cancer. In particular,
it is very difficult to differentiate between FMF AIP and PC.
Chang et al.
4 reported that 8 of 26 (31.8%) AIP patients were
FMF AIP who were frequently surgically treated because
differentiating FMFAIP from PC was so difficult. Kamisawa
et al.
3 also reported that 6 of 17 (35.3%) FMF AIP patients
were surgically treated (resection; 3, bypass operation; 3)
because PC was suspected.
To obtain images of the pancreatic duct, it is necessary to
use ERCP, and additionally direct images taken during the
operation or of specimens. Kamisawa et al.
3 reported that
the three ERCP features required for AIP diagnosis were
(1) a >3-cm-long narrowed main pancreatic duct; (2) skip
lesion of the MPD; and (3) maximal upstream MPD
diameter of <5 mm. On the other hand, features highly
suggestive of PC were a pancreatic low density mass, MPD
obstruction, distal pancreatic atrophy, and metastases. There
have been four reports of retrospective evaluation of ERCP
imaging in AIP patient.
3,5–7 The frequency of MPD
obstruction on ERCP in AIP patients was 0–5.9%, whereas
in PC patients, it was 35–60%, but only three patients with
MPD obstruction have been reported. Although the
measurement of serum IgG4 level is useful for differenti-
ating between the two diseases, 10% of PC patients also has
elevated IgG4.
8 Moreover, there are a few reports of AIP
patients with concomitant PC.
9,10 EUS-FNA is frequently
used to rule out PC. However, its accuracy for PC is not
perfect (about 70–90%) because some cases of PC are
accompanied by chronic inflammation and fibrosis around
the mass, so a negative biopsy does not rule out cancer.
Diagnosis of AIP by EUS-FNA is difficult because the
specimen is too small. Taken together, we cannot exclude
the presence of PC in many cases. Further improvement of
diagnostic strategies, such as core biopsy techniques, or
development of new immunohistological diagnostic criteria
from results of cytologic and tissue specimen analyses are
needed to avoid unnecessary surgery.
Fig. 1 Dynamic abdominal CT scans in arterial phase showed a low-
density mass (arrow) measuring 40×23 mm in the tail of the pancreas
(a). ERCP showed an obstruction of the MPD (arrow) at the site of
the pancreatic mass (b)
J Gastrointest Surg (2011) 15:2296–2298 2297In conclusion, we report an extremely rare case of
FMF AIP mimicking PC with MPD obstruction. It was
difficult to distinguish PC from AIP with current diagnostic
modalities.
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